Can cash rewards and a breathalyzer app help people stay sober?

NCT ID NCT07735585

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This trial tests whether a smartphone app called TRIS, paired with a Bluetooth breathalyzer and small daily cash rewards for verified abstinence, can help people with alcohol use disorder drink less. Participants submit three breath samples each day; those who are sober earn incentives. The study compares this approach to standard outpatient treatment alone. If it works, the app could make evidence-based sobriety support more accessible from home.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Remote contingency management delivered through a smartphone app with a Bluetooth breathalyzer and monetary incentives for verified abstinence
What this could lead to
If effective, this app-based approach could offer a scalable, convenient way to support sobriety for people with alcohol use disorder, potentially expanding access to evidence-based behavioral treatment.
What could go wrong
The trial is relatively small (130 participants) and relies on self-submitted breath samples, which may not capture all drinking episodes. The monetary incentives may not be sustainable in real-world settings, and results may not generalize beyond the Brazilian outpatient context.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IPER Research Center

    RECRUITING

    São Paulo, São Paulo, 05021-001, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.